Replies to post #80980 on Amarantus Bioscience Holdings Inc (AMBS)

[joboggi]

While Jason is hyping AMBS to some extent. If you read the fine print, he is actually coming close to reporting independently. More importantly, he has been correct so far.

[blackhawks]

Not even close, BD deal is as good as done...and IND will be filed for MANF...... I really do hope you do own some shares now and are not really just looking for a lower entry.

I just found that question below to be soooooo fricken obviously funny

Please, let's not assume certitude where there is no evidence to support it. As for 'funny', perhaps you can provide a non-humerous answer as to how/why J.N arrives at the projected share totals shown below IF either the financing he said he 'expects in weeks' materializes, or your projected 'as good as done deal' with BD materializes.

In other words, the non-dilutive funding that Gerald alluded to materializes, OR it doesn't and J.N's share projections
make sense.

It therefore seems that J.N is trying to hedge his bets/have it both ways in his analysis...deals and 'expected' funding or....dilution.

Also, we both know that AMBS pps is 'inelastic' to the content of posts! I can't drive it down with my posts....don't want to...and you can't drive it up with yours. Plenty of evidence to support THAT!

(Date of analysis can be inferred from the 'current price' date quoted in the analysis.)

http://scr.zacks.com/files/June%2019%202013_AMBS_Napodano_v001_n50g1c.pdf


A catalyst for driving valuation higher might just be raising capital to drive these opportunities forward. In this regard, we expect the company to secure upwards of $3 million in the next few weeks.

Current Price (06/19/13) $0.03

Target Price $0.25



2012 A Q1 A Q2 E Q3 E Q4 E 2013 E 2014 E 2015 E

Basic Shares Outstanding 140.7 368.2 400.0 475.0 550.0 448.3 600.0 700.0